A full-color cookbook and health guide featuring 100 recipes designed to reduce the risk and delay the onset of Alzheimer's, dementia, and memory loss, for people with a family history of these conditions or those already in the early stages, and their caregivers. Eat Smart, Stay Sharp Strong medical evidence suggests that simple changes and additions to your diet can reduce the risk or delay the onset of Alzheimer's and other forms of dementia and memory loss. In "The Alzheimer's Prevention Cookbook," Dr. Marwan Sabbagh outlines the latest evidence-based research on Alzheimer's and nutrition, and presents a dietary plan with nearly 100 recipes to enhance your health. Incorporating high-powered brain-boosting ingredients like turmeric, cinnamon, leafy greens, and even red wine, the recipes developed by Food Network star chef Beau MacMillan are also full of antioxidants, anti-inflammatories, and omega-3s. " The Alzheimer's Prevention Cookbook" is a science-to-table plan that can help prevent Alzheimer's disease, and its strategies and recipes--from sandwiches to salads and beverages to main dishes--can also diminish your chances of developing other inflammatory illnesses like heart disease, cancer, and diabetes. This combination cookbook and health guide is a powerful, proactive, and preventive approach to achieving optimum brain health.
Not many people hope to work themselves out of a job. However, Dr. Marwan Sabbagh, a board-certified neurologist and Banner Sun Health Research Institute medical director, has spent his entire career seeking to do just that as a leading researcher combating Alzheimer’s disease.
Considered one of the countrys leading experts on neurological disease research, Dr. Marwan Sabbagh is the founding director of The Cleo Roberts Center for Clinical Research at the Sun Health Research Institute in Sun City, Arizona.
The board-certified neurologist has served as principle investigator on more than 30 clinical trials related to Alzheimer's and Parkinson's diseases and has conducted research on prostate cancer and arthritis. Dr. Sabbagh received his bachelors degree from University of California at Berkeley before earning his medical degree from the University of Arizona. After completing his residency in neurology at Baylor College of Medicine, Dr. Sabbagh participated in the fellowship program studying geriatric neurology and dementia at the University of California-San Diego School of Medicine.
In addition to his ongoing clinical research, Dr. Sabbagh is the staff neurologist at the Phoenix Indian Medical Center (PIMC) and serves the medical field working in a number of educational capacities.
A third amyloid imaging agent has joined the ranks of those approved for clinical use. Piramal Imaging’s PET tracer florbetaben, now rechristened Neuraceq, got the nod from the European Medicines Agency on February 20, and from the U.S. Food and Drug Administration on March 20. At the 66th annual meeting of the American Academy of Neurology, held 26 April to 3 May in Philadelphia, Marwan Sabbagh of Banner Sun Health Research Institute in Sun City, Arizona, presented the latest data from the that helped clinch florbetaben’s approval. Previously, Sabbagh detailed early data from this trial at the 2012 AAN meeting (see ). The study suggests that a negative Neuraceq scan excludes a diagnosis of Alzheimer's disease.